Literature DB >> 11375298

Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease.

F Blandini1, R Fancellu, E Martignoni, A Mangiagalli, C Pacchetti, A Samuele, G Nappi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11375298

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  16 in total

1.  Beneficial antioxidant properties of betaine against oxidative stress mediated by levodopa/benserazide in the brain of rats.

Authors:  Masoud Alirezaei; Zeynab Khoshdel; Omid Dezfoulian; Marzyeh Rashidipour; Vahideh Taghadosi
Journal:  J Physiol Sci       Date:  2015-02-11       Impact factor: 2.781

2.  The COMT inhibitor, entacapone, reduces levodopa-induced elevations in plasma homocysteine in healthy adult rats.

Authors:  E Nissinen; H Nissinen; H Larjonmaa; A Väänänen; T Helkamaa; I Reenilä; P Rauhala
Journal:  J Neural Transm (Vienna)       Date:  2004-12-22       Impact factor: 3.575

Review 3.  Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.

Authors:  Carmen Noelker; Harald Hampel; Richard Dodel
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

4.  Effect of entacapone on plasma homocysteine levels in Parkinson's disease patients.

Authors:  Martin Nevrly; Petr Kanovsky; Hana Vranova; Katerina Langova; Petr Hlustik
Journal:  Neurol Sci       Date:  2010-05-13       Impact factor: 3.307

5.  Homocysteine and A2A-D2 Receptor-Receptor Interaction at Striatal Astrocyte Processes.

Authors:  Chiara Cervetto; Arianna Venturini; Diego Guidolin; Guido Maura; Mario Passalacqua; Carlo Tacchetti; Pietro Cortelli; Susanna Genedani; Simona Candiani; Paola Ramoino; Simone Pelassa; Manuela Marcoli; Luigi F Agnati
Journal:  J Mol Neurosci       Date:  2018-07-20       Impact factor: 3.444

6.  Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson's disease.

Authors:  Eliseu Felippe dos Santos; Estela Natacha Brandt Busanello; Anelise Miglioranza; Angela Zanatta; Alethea Gatto Barchak; Carmen Regla Vargas; Jonas Saute; Charles Rosa; Maria Júlia Carrion; Daiane Camargo; André Dalbem; Jaderson Costa da Costa; Sandro René Pinto de Sousa Miguel; Carlos Roberto de Mello Rieder; Moacir Wajner
Journal:  Metab Brain Dis       Date:  2009-03-18       Impact factor: 3.584

Review 7.  Epigenetic landscape of Parkinson's disease: emerging role in disease mechanisms and therapeutic modalities.

Authors:  Navneet Ammal Kaidery; Shaista Tarannum; Bobby Thomas
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

8.  Interaction of Memantine with Homocysteine on the Apoptosis in the Rat Hippocampus cells.

Authors:  Amin Ataie; Ramin Ataee; Mohammad Shadifar; Sima Shahabi; Seyed Mohsen Aghajanpour; Younes Hosseinpour
Journal:  Int J Mol Cell Med       Date:  2012

Review 9.  DNA methylation, a hand behind neurodegenerative diseases.

Authors:  Haoyang Lu; Xinzhou Liu; Yulin Deng; Hong Qing
Journal:  Front Aging Neurosci       Date:  2013-12-05       Impact factor: 5.750

10.  Homocysteine Level and Mechanisms of Injury in Parkinson's Disease as Related to MTHFR, MTR, and MTHFD1 Genes Polymorphisms and L-Dopa Treatment.

Authors:  Agata Rozycka; Pawel P Jagodzinski; Wojciech Kozubski; Margarita Lianeri; Jolanta Dorszewska
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.